Related Experiment Video
Updated: Nov 6, 2025

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Patient-Reported Outcomes in Cardiovascular Trials.
Ruth Masterson Creber1, Cristiano Spadaccio2, Arnaldo Dimagli3
1Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.
Patient-reported outcomes (PROs) enhance cardiac clinical trials by capturing patient well-being. Addressing challenges in PRO measurement offers opportunities to improve trial validity and patient-centered care.
Area of Science:
- Cardiology
- Clinical Trials
- Patient-Reported Outcomes
Background:
- Patient-reported outcomes (PROs) offer insights into patient well-being across global, mental, physical, and social health domains.
- PROs are crucial for evaluating treatment efficacy and patient experience in clinical research.
Purpose of the Study:
- To review the application of PROs in cardiac clinical trials, particularly for coronary heart disease and heart failure surgical trials.
- To identify current challenges and propose future opportunities for advancing PRO utilization in cardiac research.
Main Methods:
- Descriptive review of literature on PROs in cardiac clinical trials.
- Analysis of challenges and opportunities in PRO measurement and application.
Main Results:
- Key challenges include long-term PRO measurement (beyond 1 year), inconsistent outcome measure selection, and lack of multi-domain PRO assessment.
- Opportunities include leveraging consumer health informatics tools and data visualization for participant feedback.
Conclusions:
- Advancing cardiac clinical trials requires addressing PRO measurement inconsistencies and duration limitations.
- Future research should focus on integrating novel technologies and defining cohort-specific minimal clinically important differences for PROs to enhance patient-centered care.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Clinical Trials: Overview
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Cardiovascular Drugs: Classification based on Therapeutic Indications
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...

